(Q36621638)

15 August 2017

0 references

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance (English)

1 reference

15 August 2017

1 reference

1 reference

S L Deming

1

1 reference

15 August 2017

S J Nass

series ordinal

2

1 reference

15 August 2017

R B Dickson

series ordinal

3

1 reference

15 August 2017

B J Trock

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

12

1 reference

15 August 2017

1688-1695

1 reference

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

c-Myc target genes involved in cell growth, apoptosis, and metabolism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin d.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

The molecular genetics of cellular oncogenes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Meta-analysis: State-of-the-Science

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Defining a role for c-Myc in breast tumorigenesis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Analysis of genetic alterations related to the development and progression of breast carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Planning the size and duration of a clinical trial studying the time to some critical event

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Analysis of oncogenes and tumor suppressor genes in human breast cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

[Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors]

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Proto-oncogene amplification and human breast tumor phenotype

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363455

Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis

21 October 2018

1 reference

12 December 2020

Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer

1 reference

12 December 2020

Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients

1 reference

12 December 2020

A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer

1 reference

12 December 2020

Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations

1 reference

12 December 2020

Oncogene amplification per se: an independent prognostic factor in human breast cancer

1 reference

12 December 2020

High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers

1 reference

12 December 2020

Prognostic value of erb-B2 and myc amplification in breast cancer imprints

1 reference

12 December 2020

c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients

1 reference

12 December 2020

Assessing sequential oncogene amplification in human breast cancer

1 reference

12 December 2020

Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization

1 reference

12 December 2020

Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms

1 reference

12 December 2020

Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas

1 reference

12 December 2020

Amplification and expression of the c-myc oncogene in human lung cancer cell lines

1 reference

12 December 2020

Alteration of morphogenesis by the v-myc oncogene in transplants of mammary gland

1 reference

12 December 2020

In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors

1 reference

12 December 2020

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis

1 reference

12 December 2020

Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis

1 reference

12 December 2020

Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease

1 reference

12 December 2020

Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1

1 reference

12 December 2020

Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas

1 reference

12 December 2020

Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness

1 reference

12 December 2020

Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas

1 reference

12 December 2020

Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas

1 reference

12 December 2020

c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1522

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11104567

1 reference